Outcomes of Medicare Beneficiaries With Heart Failure and Atrial Fibrillation

Mountantonakis, 2012, Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of Get With The Guidelines-Heart Failure, Circ Heart Fail, 5, 191, 10.1161/CIRCHEARTFAILURE.111.965681

Ahmed, 2004, Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure, Eur J Heart Fail, 6, 421, 10.1016/j.ejheart.2003.11.011

Dries, 1998, J Am Coll Cardiol, 32, 695, 10.1016/S0735-1097(98)00297-6

Olsson, 2006, Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program, J Am Coll Cardiol, 47, 1997, 10.1016/j.jacc.2006.01.060

Rivero-Ayerza, 2008, New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey, Eur Heart J, 29, 1618, 10.1093/eurheartj/ehn217

Swedberg, 2005, Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET, Eur Heart J, 26, 1303, 10.1093/eurheartj/ehi166

Carson, 1993, The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group, Circulation, 87, VI102

Hong, 2006, Overview of the American Heart Association “Get with the Guidelines” programs: coronary heart disease, stroke, and heart failure, Crit Pathw Cardiol, 5, 179, 10.1097/01.hpc.0000243588.00012.79

Fonarow, 2004, Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design, Am Heart J, 148, 43, 10.1016/j.ahj.2004.03.004

Hammill, 2009, Linking inpatient clinical registry data to Medicare claims data using indirect identifiers, Am Heart J, 157, 995, 10.1016/j.ahj.2009.04.002

Jensen, 2012, A systematic review of validated methods for identifying atrial fibrillation using administrative data, Pharmacoepidemiol Drug Saf, 21, 141, 10.1002/pds.2317

Birman-Deych, 2005, Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors, Med Care, 43, 480, 10.1097/01.mlr.0000160417.39497.a9

Roumie, 2008, Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data, Pharmacoepidemiol Drug Saf, 17, 20, 10.1002/pds.1518

Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002

Keenan, 2008, An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure, Circ Cardiovasc Qual Outcomes, 1, 29, 10.1161/CIRCOUTCOMES.108.802686

Krumholz, 2006, An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure, Circulation, 113, 1693, 10.1161/CIRCULATIONAHA.105.611194

Kalbfleisch, 2002

Gray, 1988, A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann Stat, 16, 1141, 10.1214/aos/1176350951

Harrell, 2010

Nieuwlaat, 2005, Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, Eur Heart J, 26, 2422, 10.1093/eurheartj/ehi505

Nieuwlaat, 2008, Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation, Eur Heart J, 29, 1181, 10.1093/eurheartj/ehn139

Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638

Fuster, 2011, J Am Coll Cardiol, 57, e100, 10.1016/j.jacc.2010.09.013

Badheka, 2011, Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction, Am J Cardiol, 108, 1283, 10.1016/j.amjcard.2011.06.045

van Diepen, 2013, Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF, Circ Heart Fail, 6, 740, 10.1161/CIRCHEARTFAILURE.113.000212

McMurray, 2013, Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial, Circ Heart Fail, 6, 451, 10.1161/CIRCHEARTFAILURE.112.000143

Heidenreich, 2006, Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts, Am Heart J, 152, 935, 10.1016/j.ahj.2006.06.037

Curtis, 2007, Validity of a national heart failure quality of care registry: comparison of Medicare patients in OPTIMIZE-HF versus non-OPTIMIZE-HF hospitals, Circulation, 115, e595

Quach, 2010, Administrative data have high variation in validity for recording heart failure, Can J Cardiol, 26, 306, 10.1016/S0828-282X(10)70438-4

Kokotailo, 2005, Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10, Stroke, 36, 1776, 10.1161/01.STR.0000174293.17959.a1